Name: | Y-MABS THERAPEUTICS, INC. |
Jurisdiction: | New York |
Legal type: | FOREIGN BUSINESS CORPORATION |
Status: | Active |
Date of registration: | 04 Sep 2015 (9 years ago) |
Entity Number: | 4815574 |
ZIP code: | 10005 |
County: | New York |
Place of Formation: | Delaware |
Address: | 28 LIBERTY STREET, NEW YORK, NY, United States, 10005 |
Principal Address: | 202 carnegie center, PRINCETON, NJ, United States, 08540 |
Plan Name | Plan Year | EIN/PN | Received | Sponsor | Total number of participants | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Y-MABS THERAPEUTICS INC-401K PLAN | 2019 | 474619612 | 2020-07-28 | Y-MABS THERAPEUTICS INC | 8 | |||||||||||||||||||||
|
Role | Plan administrator |
Date | 2020-07-28 |
Name of individual signing | MICHAEL MILLIGAN |
File | View Page |
Three-digit plan number (PN) | 001 |
Effective date of plan | 2018-01-01 |
Business code | 325410 |
Sponsor’s telephone number | 4042717208 |
Plan sponsor’s address | 230 PARK AVE, SUITE 3350, NEW YORK, NY, 10169 |
Signature of
Role | Plan administrator |
Date | 2019-05-30 |
Name of individual signing | MICHAEL MILLIGAN |
Name | Role | Address |
---|---|---|
C/O C T CORPORATION SYSTEM | DOS Process Agent | 28 LIBERTY STREET, NEW YORK, NY, United States, 10005 |
Name | Role | Address |
---|---|---|
MICHAEL ROSSI | Chief Executive Officer | 202 CARNEGIE CENTER, PRINCETON, NJ, United States, 08540 |
Start date | End date | Type | Value |
---|---|---|---|
2025-01-07 | 2025-01-07 | Address | C/O Y-MABS THERAPEUTICS, INC., 230 PARK AVENUE, 33RD FLOOR, NEW YORK, NY, 10169, USA (Type of address: Chief Executive Officer) |
2025-01-07 | 2025-01-07 | Address | 202 CARNEGIE CENTER, PRINCETON, NJ, 08540, USA (Type of address: Chief Executive Officer) |
2025-01-07 | 2025-01-07 | Address | 230 PARK AVE, STE 3350, NEW YORK, NY, 10169, USA (Type of address: Chief Executive Officer) |
2023-09-01 | 2025-01-07 | Address | C/O Y-MABS THERAPEUTICS, INC., 230 PARK AVENUE, 33RD FLOOR, NEW YORK, NY, 10169, USA (Type of address: Chief Executive Officer) |
2023-09-01 | 2023-09-01 | Address | 230 PARK AVE, STE 3350, NEW YORK, NY, 10169, USA (Type of address: Chief Executive Officer) |
2023-09-01 | 2023-09-01 | Address | C/O Y-MABS THERAPEUTICS, INC., 230 PARK AVENUE, 33RD FLOOR, NEW YORK, NY, 10169, USA (Type of address: Chief Executive Officer) |
2023-09-01 | 2025-01-07 | Address | 28 LIBERTY STREET, NEW YORK, NY, 10005, USA (Type of address: Service of Process) |
2019-07-09 | 2023-09-01 | Address | 28 LIBERTY STREET, NEW YORK, NY, 10005, USA (Type of address: Service of Process) |
2018-09-19 | 2023-09-01 | Address | C/O Y-MABS THERAPEUTICS, INC., 230 PARK AVENUE, 33RD FLOOR, NEW YORK, NY, 10169, USA (Type of address: Chief Executive Officer) |
2015-09-04 | 2019-07-09 | Address | C/O CT CORPORATION SYSTEM, 111 EIGHTH AVENUE, NEW YORK, NY, 10011, USA (Type of address: Service of Process) |
Filing Number | Date Filed | Type | Effective Date |
---|---|---|---|
250107000172 | 2025-01-06 | AMENDMENT TO BIENNIAL STATEMENT | 2025-01-06 |
230901006739 | 2023-09-01 | BIENNIAL STATEMENT | 2023-09-01 |
210901002906 | 2021-09-01 | BIENNIAL STATEMENT | 2021-09-01 |
190913060218 | 2019-09-13 | BIENNIAL STATEMENT | 2019-09-01 |
190709000153 | 2019-07-09 | CERTIFICATE OF CHANGE | 2019-07-09 |
180919006299 | 2018-09-19 | BIENNIAL STATEMENT | 2017-09-01 |
150904000210 | 2015-09-04 | APPLICATION OF AUTHORITY | 2015-09-04 |
Contract Type | Award or IDV Flag | PIID | Start Date | Current End Date | Potential End Date | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No data | IDV | 36F79721D0228 | 2021-09-01 | No data | No data | |||||||||||||||||||||||
|
Obligated Amount | 0.00 |
Potential Award Amount | 2160000.00 |
Description
Title | ADMIN CHANGE SAF AND POC UPDATE |
NAICS Code | 325412: PHARMACEUTICAL PREPARATION MANUFACTURING |
Product and Service Codes | 6505: DRUGS AND BIOLOGICALS |
Recipient Details
Recipient | Y-MABS THERAPEUTICS, INC |
UEI | ES3KM3NR11K8 |
Recipient Address | UNITED STATES, 230 PARK AVE FL 33 STE 3350, NEW YORK, NEW YORK, NEW YORK, 101693302 |
Date of last update: 01 Feb 2025
Sources: New York Secretary of State